Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 10MG/ML | 0 | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1961-04-11 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 13 | AP | 1981-03-09 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 17 | AP | 1981-03-02 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 1980-03-04 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 21 | AP | 1981-03-02 | STANDARD |
LABELING; Labeling | SUPPL | 22 | AP | 1980-06-23 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 1980-09-03 | STANDARD |
LABELING; Labeling | SUPPL | 24 | AP | 1981-03-23 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 25 | AP | 1981-06-25 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 26 | AP | 1995-10-02 | STANDARD |
LABELING; Labeling | SUPPL | 28 | AP | 1984-05-21 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 1983-03-15 | STANDARD |
LABELING; Labeling | SUPPL | 31 | AP | 1985-09-20 | STANDARD |
LABELING; Labeling | SUPPL | 32 | AP | 1986-07-10 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 1991-06-24 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 34 | AP | 1988-12-12 | STANDARD |
LABELING; Labeling | SUPPL | 35 | AP | 1991-06-24 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 36 | AP | 1989-07-28 | STANDARD |
LABELING; Labeling | SUPPL | 39 | AP | 2000-04-05 | STANDARD |
LABELING; Labeling | SUPPL | 40 | AP | 2000-04-05 | STANDARD |
LABELING; Labeling | SUPPL | 41 | AP | 2000-04-05 | STANDARD |
LABELING; Labeling | SUPPL | 42 | AP | 2000-04-05 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 43 | AP | 1998-12-24 | STANDARD |
LABELING; Labeling | SUPPL | 44 | AP | 2000-04-05 | STANDARD |
LABELING; Labeling | SUPPL | 45 | AP | 2001-03-27 | STANDARD |
LABELING; Labeling | SUPPL | 46 | AP | 2003-07-29 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 0 |
SUPPL | 13 | Null | 0 |
SUPPL | 17 | Null | 0 |
SUPPL | 19 | Null | 0 |
SUPPL | 21 | Null | 0 |
SUPPL | 22 | Null | 0 |
SUPPL | 23 | Null | 0 |
SUPPL | 24 | Null | 0 |
SUPPL | 25 | Null | 0 |
SUPPL | 26 | Null | 0 |
SUPPL | 28 | Null | 0 |
SUPPL | 30 | Null | 0 |
SUPPL | 31 | Null | 0 |
SUPPL | 32 | Null | 0 |
SUPPL | 33 | Null | 0 |
SUPPL | 34 | Null | 0 |
SUPPL | 35 | Null | 0 |
SUPPL | 36 | Null | 0 |
SUPPL | 39 | Null | 0 |
SUPPL | 40 | Null | 0 |
SUPPL | 41 | Null | 0 |
SUPPL | 42 | Null | 0 |
SUPPL | 43 | Null | 0 |
SUPPL | 44 | Null | 0 |
SUPPL | 45 | Null | 0 |
SUPPL | 46 | Null | 0 |
CDER Filings
ASTRAZENECA
cder:Array
(
[0] => Array
(
[ApplNo] => 12704
[companyName] => ASTRAZENECA
[docInserts] => ["",""]
[products] => [{"drugName":"ELAVIL","activeIngredients":"AMITRIPTYLINE HYDROCHLORIDE","strength":"10MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ELAVIL","submission":"AMITRIPTYLINE HYDROCHLORIDE","actionType":"10MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)